BRICS Spinal Cord Stimulation Devices Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033

Growing Demand for Pain Relief

The demand for BRICS SCS devices is expected to witness significant growth in coming years owing to the high prevalence of various chronic pain disorders like neuropathic pain, failed back syndrome, spinal degeneration-related pain etc. The population suffering from chronic pain disorders is rapidly increasing in these economies owing to the prevalence of aged demographics, manual working industries, and the occurrence of lifestyle-related health disorders. A considerable percentage of the adult population in BRICS countries is suffering from chronic pain that needs modern treatment techniques such as neuromodulation.

Hospitals in large urban centers have witnessed an increasing number of patients who respond inadequately to traditional treatments for their pain disorder, which includes conventional medications and physical therapy. Spinal cord stimulators are increasingly being adopted in these hospitals for treating spinal pain, which includes post-operative spinal pain and diabetic neuropathy-related disorders. An increasing number of spinal surgeries performed in BRICS economies has also resulted in chronic post-operative pain conditions among people.

Further, knowledge about pain management using advanced technology is slowly spreading in emerging health care systems. Spinal cord stimulation is becoming popular among physicians as a long-term remedy for patients suffering from chronic pain, where they do not have easy access to consistent medication. More than one point five billion people worldwide suffer from chronic pain problems, including many people from the emerging countries.

Expanding Telemedicine Integration Systems

The growth in demand for spinal cord stimulators within the BRICS nations is further augmented by the fast development of telemedicine and remote monitoring technologies that help to increase access to chronic pain management among the dispersed population. Digital healthcare solutions are increasingly used to provide follow-up treatment for patients that have received their implants in order to limit the need for in-patient visits and promote better therapy compliance.

In large urban areas, hospitals as well as specialized pain management centers integrate remote programming features into SCS devices in order to allow physicians to make changes in stimulation parameters without having to consult with patients personally. Moreover, initial deployment of AI-powered monitoring technologies has made it possible to develop more personalized strategies for pain management based on feedback and usage trends.

The development of telemedicine solutions also helps to increase access to neuromodulation in semi-urban and underserved areas, as it provides patients with preliminary consultations and follow-up treatment via digital tools, while implantation takes place at specialized facilities located in major metropolitan centers.

The "BRICS Spinal Cord Stimulation Devices Market Size and Forecast (2022-2033)" report provides a detailed analysis of the market covering below areas:

• Market size and forecast at regional and country levels for all market segments covered under the scope
• Market trends, as well as drivers, restraints, and opportunities
• Market analysis covering key trends, regional framework, major players, regulations, and recent developments
• Market concentration, heat map analysis, prominent players, and recent developments for the Market
• Detailed company profiles, including SWOT analysis

The geographical scope of the BRICS spinal cord stimulation devices market report is divided into: Russia, Brazil, South Africa, India, China, Egypt, Indonesia, Saudi Arabia, and the UAE. China held the largest share in 2025.

China leads in terms of the spinal cord stimulation device market in BRICS based on the huge patient base, development of the healthcare infrastructure, and investments made in high-end medical technology equipment. There have been notable developments in the tertiary hospitals and specialized neurosurgical hospitals in many urban areas where the introduction of the advanced chronic pain services has started. Patients suffering from complex neuropathic pain conditions, failed back surgery syndrome, and degenerative diseases of the spine are benefiting from this procedure when other treatment methods fail. One reason behind the dominance of the Chinese spinal cord stimulators market can be attributed to the advancements that are taking place in the country's health care industry, which allows better access to sophisticated procedures and stimulates the adoption of neuromodulation devices in the best hospitals. Specialists working in such hospitals get accustomed to the international treatment standards which is helping them incorporate this treatment into the standardized pain management pathway. Nonetheless, implementation is skewed towards urban areas, as well as high-income areas, because of the costs associated with the implantation of neuromodulation devices. The public health centers tend to offer only necessary health services, thereby hindering wider availability. Additionally, awareness concerning these pain therapies is relatively low among doctors and patients. There are further issues with other members of the BRICS group due to poor infrastructure and high prices. Hence, the Chinese nation has continued playing a central role in the growth of spinal cord stimulation in the BRICS nations due to improved health care systems and increased demand for pain therapy products.

• The report includes qualitative and quantitative data in the BRICS spinal cord stimulation devices market across product type, type, application, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the BRICS spinal cord stimulation devices market.
• Chapter 3 focuses on the research methodology of the study.
• Chapter 4 includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the BRICS spinal cord stimulation devices market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the BRICS spinal cord stimulation devices market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 11 cover the BRICS spinal cord stimulation devices market segments by product type, type, application, end user, and geography across Russia, Brazil, South Africa, India, China, Egypt, Indonesia, Saudi Arabia, and the UAE. They cover the market revenue, forecast, and factors driving the market.
• Chapter 12 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 13 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 14 provides detailed profiles of the major companies operating in the BRICS spinal cord stimulation devices market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 15, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The BRICS spinal cord stimulation devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the BRICS spinal cord stimulation devices market are:

• In May 2025, Abbott announced that its Eterna spinal cord stimulation system received approval from ANVISA, expanding access to its low-dose BurstDR neuromodulation therapy for chronic pain patients in Brazil, one of the largest SCS adoption markets in Latin America and a key BRICS healthcare market.
• In August 2023, Medtronic announced that it received CE Mark approval for its Inceptiv closed-loop spinal cord stimulation system, enabling expanded international commercialization pathways into BRICS-linked markets such as Brazil, India, and South Africa, where CE-marked neuromodulation devices are commonly adopted ahead of local regulatory clearance.